Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James R Perry

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Current Opinion in Neurology|October 1, 2010
Anticoagulation of malignant glioma patients in the era of novel antiangiogenic agentsJames R Perry
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|April 11, 2014
Glioblastoma: If this is the "Temozolomide Era" Where is the Evidence?James R Perry
Neuro-Oncology|October 26, 2012
Thromboembolic disease in patients with high-grade gliomaJames R Perry
Neuro-Oncology Practice|March 18, 2024
A longer and/or better life for the oldest old with glioblastomaKatrina Roberto, James R Perry
Handbook of Clinical Neurology|March 8, 2016
Vascular complications in glioma patientsEmilie Le Rhun, James R Perry
Postgraduate Medicine|December 9, 2017
Carotid artery stenosisCheryl S Jaigobin, James R Perry
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 13, 2003
Glioma therapies: how to tell which work?James R Perry, J Gregory Cairncross
Frontiers in Oncology|February 22, 2020
Commentary: Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated <i>MGMT</i> promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trialSunit Das, Arjun Sahgal, James R Perry
The New England Journal of Medicine|June 1, 2017
Radiation plus Temozolomide in Patients with GlioblastomaJames R Perry, Normand Laperriere, Warren P Mason
Seminars in Thrombosis and Hemostasis|March 7, 2014
Thrombosis in brain tumorsJasmin T Jo, David Schiff, James R Perry
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Current Opinion in Neurology|October 1, 2010
Anticoagulation of malignant glioma patients in the era of novel antiangiogenic agentsJames R Perry
The Canadian Journal of Neurological Sciences. Le Journal Canadien Des Sciences Neurologiques|April 11, 2014
Glioblastoma: If this is the "Temozolomide Era" Where is the Evidence?James R Perry
Neuro-Oncology|October 26, 2012
Thromboembolic disease in patients with high-grade gliomaJames R Perry
Neuro-Oncology Practice|March 18, 2024
A longer and/or better life for the oldest old with glioblastomaKatrina Roberto, James R Perry
Handbook of Clinical Neurology|March 8, 2016
Vascular complications in glioma patientsEmilie Le Rhun, James R Perry
Postgraduate Medicine|December 9, 2017
Carotid artery stenosisCheryl S Jaigobin, James R Perry
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 13, 2003
Glioma therapies: how to tell which work?James R Perry, J Gregory Cairncross
Frontiers in Oncology|February 22, 2020
Commentary: Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated <i>MGMT</i> promoter (CeTeG/NOA-09): a randomised, open-label, phase 3 trialSunit Das, Arjun Sahgal, James R Perry
The New England Journal of Medicine|June 1, 2017
Radiation plus Temozolomide in Patients with GlioblastomaJames R Perry, Normand Laperriere, Warren P Mason
Seminars in Thrombosis and Hemostasis|March 7, 2014
Thrombosis in brain tumorsJasmin T Jo, David Schiff, James R Perry
Pageof 5